A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses

A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses

The tremendous global impact of the current SARS-CoV-2 pandemic, as well as other current and recent outbreaks of (re)emerging viruses, emphasize the need for fast-track development of effective vaccines. Yellow fever virus 17D (YF17D) is a live-attenuated virus vaccine with an impressive efficacy r...

Full description

Bibliographic Details
Main Authors: Nadia Oreshkova, Sebenzile K. Myeni, Niraj Mishra, Irina C. Albulescu, Tim J. Dalebout, Eric J. Snijder, Peter J. Bredenbeek, Kai Dallmeier, Marjolein Kikkert
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Vaccines
Subjects:
coronavirus
vaccine platform
YFV-17D
YF17D
MERS-CoV
SARS-CoV
Online Access:https://www.mdpi.com/2076-393X/9/12/1492

Similar Items

Similar Items